Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Seno, Akimasa  [Clear All Filters]
2020
Hassan G, Du J, Afify SM, Seno A, Seno M. Cancer stem cell generation by silenced MAPK enhancing PI3K/AKT signaling. Med Hypotheses. 2020;141:109742.
Osman A, Oze M, Afify SM, Hassan G, El-Ghlban S, Nawara HM, Fu X, Zahra MHussein, Seno A, Winer I, et al. Tumor-associated macrophages derived from cancer stem cells. Acta Histochem. 2020;122(8):151628.
2021
Afify SM, Hassan G, Yan T, Seno A, Seno M. Cancer Stem Cell Initiation by Tumor-Derived Extracellular Vesicles. Methods Mol Biol. 2021.
Bi Z, Zhang Q, Fu Y, Seno A, Wadgaonkar P, Qiu Y, Almutairy B, Xu L, Zhang W, Thakur C, et al. Cooperation between NRF2-mediated transcription and MDIG-dependent epigenetic modifications in arsenic-induced carcinogenesis and cancer stem cells. Semin Cancer Biol. 2021.
Hassan G, Afify SM, Du J, Nawara HM, Sheta M, Monzur S, Zahra MH, Quora HAAbu, Mansour H, El-Ghlban S, et al. MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway. Biochem Biophys Res Commun. 2021;583:49-55.
2022
Zahra MH, Nawara HM, Hassan G, Afify SM, Seno A, Seno M. Cancer Stem Cells Contribute to Drug Resistance in Multiple Different Ways. Adv Exp Med Biol. 2022;1393:125-139.
Minematsu H, Afify SM, Sugihara Y, Hassan G, Zahra MH, Seno A, Adachi M, Seno M. Cancer stem cells induced by chronic stimulation with prostaglandin E2 exhibited constitutively activated PI3K axis. Sci Rep. 2022;12(1):15628.
Afify SM, Hassan G, Ishii H, Monzur S, Nawara HM, Osman A, Quora HAAbu, Sheta M, Zahra MH, Seno A, et al. Functional and Molecular Characters of Cancer Stem Cells Through Development to Establishment. Adv Exp Med Biol. 2022;1393:83-101.
2023
Hassan G, Afify SM, Zahra MH, Nawara HM, Kumon K, Iwasaki Y, Salomon DS, Seno A, Seno M. GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation. Cytotechnology. 2023;75(3):243-253.
Wang Z, Fu Y, Seno A, Bi Z, Pawar AS, Ji H, Almutairy BSaeed, Qiu Y, Zhang W, Thakur C, et al. Tumor suppressive activity of AHR in environmental arsenic-induced carcinogenesis. Toxicol Appl Pharmacol. 2023:116747.
2024
Ji H, Bi Z, Pawar AS, Seno A, Almutairy BSaeed, Fu Y, Qiu Y, Zhang W, Wang Z, Thakur C, et al. Genomic and epigenetic characterization of the arsenic-induced oncogenic microRNA-21. Environ Pollut. 2024:123396.